Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David S Geldmacher

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Frontiers in Bioscience : a Journal and Virtual Library|September 6, 2003
Visuospatial dysfunction in the neurodegenerative diseasesDavid S Geldmacher
Neuropsychiatric Disease and Treatment|October 3, 2008
Cost-effectiveness of drug therapies for Alzheimer's disease: A brief reviewDavid S Geldmacher
Primary Care Companion to the Journal of Clinical Psychiatry|June 24, 2004
Long-Term Cholinesterase Inhibitor Therapy for Alzheimer's Disease: Practical Considerations for the Primary Care PhysicianDavid S. Geldmacher
Primary Care Companion to the Journal of Clinical Psychiatry|July 4, 2007
Treatment guidelines for Alzheimer's disease: redefining perceptions in primary careDavid S Geldmacher
Continuum (Minneapolis, Minn.)|December 2, 2024
Treatment of Alzheimer DiseaseDavid S Geldmacher
Seminars in Neurology|August 10, 2002
Cost-effective recognition and diagnosis of dementiaDavid S Geldmacher
Managed Care (Langhorne, Pa.)|January 13, 2006
The cost benefit to health plans of pharmacotherapy for Alzheimer's diseaseDavid S Geldmacher
Cleveland Clinic Journal of Medicine|November 9, 2004
Dementia with Lewy bodies: diagnosis and clinical approachDavid S Geldmacher
Cleveland Clinic Journal of Medicine|October 5, 2010
Alzheimer disease prevention: focus on cardiovascular risk, not amyloid?David S Geldmacher
Expert Review of Neurotherapeutics|April 28, 2005
Donepezil (Aricept) for treatment of Alzheimer's disease and other dementing conditionsDavid S Geldmacher
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Frontiers in Bioscience : a Journal and Virtual Library|September 6, 2003
Visuospatial dysfunction in the neurodegenerative diseasesDavid S Geldmacher
Neuropsychiatric Disease and Treatment|October 3, 2008
Cost-effectiveness of drug therapies for Alzheimer's disease: A brief reviewDavid S Geldmacher
Primary Care Companion to the Journal of Clinical Psychiatry|June 24, 2004
Long-Term Cholinesterase Inhibitor Therapy for Alzheimer's Disease: Practical Considerations for the Primary Care PhysicianDavid S. Geldmacher
Primary Care Companion to the Journal of Clinical Psychiatry|July 4, 2007
Treatment guidelines for Alzheimer's disease: redefining perceptions in primary careDavid S Geldmacher
Continuum (Minneapolis, Minn.)|December 2, 2024
Treatment of Alzheimer DiseaseDavid S Geldmacher
Seminars in Neurology|August 10, 2002
Cost-effective recognition and diagnosis of dementiaDavid S Geldmacher
Managed Care (Langhorne, Pa.)|January 13, 2006
The cost benefit to health plans of pharmacotherapy for Alzheimer's diseaseDavid S Geldmacher
Cleveland Clinic Journal of Medicine|November 9, 2004
Dementia with Lewy bodies: diagnosis and clinical approachDavid S Geldmacher
Cleveland Clinic Journal of Medicine|October 5, 2010
Alzheimer disease prevention: focus on cardiovascular risk, not amyloid?David S Geldmacher
Expert Review of Neurotherapeutics|April 28, 2005
Donepezil (Aricept) for treatment of Alzheimer's disease and other dementing conditionsDavid S Geldmacher
Pageof 6